| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A detailed description of the distress trajectory from pre- to post-treatment in breast cancer patients receiving neoadjuvant chemotherapy
|
Lacourt, Tamara E.
|
|
|
197 |
2 |
p. 299-305
|
artikel
|
| 2 |
A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia
|
Kechin, Andrey
|
|
|
197 |
2 |
p. 387-395
|
artikel
|
| 3 |
Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients
|
Joyce, Elizabeth
|
|
|
197 |
2 |
p. 397-404
|
artikel
|
| 4 |
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer
|
Noteware, Laura
|
|
|
197 |
2 |
p. 425-434
|
artikel
|
| 5 |
Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study
|
Acevedo, Francisco
|
|
|
197 |
2 |
p. 449-459
|
artikel
|
| 6 |
Correlation analysis between shear-wave elastography and pathological profiles in breast cancer
|
Li, Junnan
|
|
|
197 |
2 |
p. 269-276
|
artikel
|
| 7 |
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
|
Glynn, David
|
|
|
197 |
2 |
p. 405-416
|
artikel
|
| 8 |
Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
|
Mamtani, Anita
|
|
|
197 |
2 |
p. 417-423
|
artikel
|
| 9 |
Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer
|
Burnette, Sarah E.
|
|
|
197 |
2 |
p. 369-376
|
artikel
|
| 10 |
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers
|
Ogony, Joshua
|
|
|
197 |
2 |
p. 277-285
|
artikel
|
| 11 |
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
|
Yazaki, Shu
|
|
|
197 |
2 |
p. 287-297
|
artikel
|
| 12 |
Neo-peripheral adaptive immune score predicts neoadjuvant chemotherapy for locally advanced breast cancer
|
Wang, Huiling
|
|
|
197 |
2 |
p. 343-354
|
artikel
|
| 13 |
Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer
|
Bergman, Riley
|
|
|
197 |
2 |
p. 307-317
|
artikel
|
| 14 |
Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database
|
Kawai, Masaaki
|
|
|
197 |
2 |
p. 435-447
|
artikel
|
| 15 |
Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry
|
Kada Mohammed, Samia
|
|
|
197 |
2 |
p. 377-385
|
artikel
|
| 16 |
Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis
|
Shiino, Sho
|
|
|
197 |
2 |
p. 245-254
|
artikel
|
| 17 |
Return of individual genomic research results within the PRAEGNANT multicenter registry study
|
Huebner, Hanna
|
|
|
197 |
2 |
p. 355-368
|
artikel
|
| 18 |
Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis
|
Yang, Zhengyan
|
|
|
197 |
2 |
p. 255-267
|
artikel
|
| 19 |
The impact of neoadjuvant systemic treatment on postoperative complications in breast cancer surgery
|
Nussbaumer, R. L.
|
|
|
197 |
2 |
p. 333-341
|
artikel
|
| 20 |
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
|
Bardia, Aditya
|
|
|
197 |
2 |
p. 319-331
|
artikel
|
Tijdschrift beschrijving